Travelers returning from Europe frequently report a curious experience. They eat pasta, bread, and rich cuisine, but somehow ...

The partnership follows news from Oct. 16 that the company has partnered with Ardena, a specialist pharmaceutical contract development and manufacturing organization, to manufacture the startup’s ...

Niagen Bioscience posts record Q3 revenue, boosted by Tru Niagen and new partnerships. Read here for an investment analysis of NAGE stock.

The approval was based on the phase 3 ZENITH trial, which evaluated sotatercept in PAH adults aged 18 years and older with WHO FC II or IV at high risk of mortality.

Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the Committee for Medicinal Products ...

A San Antonio woman has spent the last decade developing a product and creating a company that aims to clearly label IV ...

The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...

Background Globally, an estimated 296 million individuals live with chronic hepatitis B virus (HBV) infection, carrying ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

An application for subcutaneous induction dosing with Leqembi Iqlik was initiated in the US Net revenues amounted to SEK 133.3 M (76.6), of which SEK 117.2 M (69.8) in royalties for Leqembi and SEK 8.